2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
3
Leukemia, Myelomonocytic, Chronic
1
Interventions
Cyclophosphamide
78
fludarabine phosphate
77
Azacitidine
76
Peripheral Blood Stem Cell Transplantation
63
Busulfan
53
Mycophenolic Acid
51
Whole-Body Irradiation
50
Tacrolimus
48
Cytarabine
43
Cyclosporine
43
Methotrexate
37
Decitabine
36
Filgrastim
32
Antilymphocyte Serum
30
venetoclax
27
Radiotherapy
25
Melphalan
23
fludarabine
22
Etoposide
18
Methylprednisolone
17
Biopsy
15
Cyclosporins
14
Specimen Handling
13
Injections
13
Granulocyte Colony-Stimulating Factor
13
Flow Cytometry
13
Cord Blood Stem Cell Transplantation
13
decitabine and cedazuridine drug combination
12
Idarubicin
12
Stem Cell Transplantation
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
bisantrene
×
Clear all
NCT05456269
2023-10-03
BISECT
Racura Oncology Ltd
Phase 1
Withdrawn